CompletedNCT00260962
Olanzapine in the Treatment of Patients With Eating disorders
Medication studyAges 18+Canada
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- OttawaSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateSeptember 2000
- Recruitment status
- Completed
- Enrollment listed in the registry
- 34
- Sponsor
- Ottawa Hospital Research Institute
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Psychotherapy / behavioral intervention, Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Canada
- Age range
- Over 18 Years
- Official registry ID
- NCT00260962
- Official title
Show the full official title
Olanzapine in the Treatment of Low Weight and Obsessional Thinking Among Those With Anorexia Nervosa: A Double Blind Placebo Controlled Study
Get this study by email
Recruitment & locations
CompletedOttawa
Questions about this study
Who is behind this study?
The study sponsor is Ottawa Hospital Research Institute, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Olanzapine.
Who was this study for?
Listed age limits: from 18 years.
Want to explore more studies?
Explore studiesRelated studies
A Comparison of Methylphenidate and Cognitive Behavioural Therapy for the Treatment of Binge Eating disorders
Effectiveness of Atypical Antipsychotic Medication for Outpatients With Eating disorders